Restylane is a gel-based injection of hyaluronic acid, a compound that the body produces naturally. The gel reduces wrinkles and folds in the face, and can also add volume to the lips. Perlane and Perlane-L are also available as part of the Restylane product line. The injections create a more youthful-looking face, minimizing the appearance of a variety of wrinkles that occur around the nose and mouth area. People with severe allergies that have required hospitalization should not use Restylane products, nor should people with bleeding disorders. A doctor can help determine whether a person should or should not use Restylane treatments.
Dr. Coyle Connolly is President of Connolly Dermatology in New Jersey. With years of experience in the field of dermatology, Dr. Connolly offers a number of skin care procedures of all varieties. Dr. Coyle Connolly's offices specialize in medical and general dermatology, including procedures that treat skin cancer and other dermatological issues, in addition to cosmetic procedures like microderm abrasions, chemical peels, Botox and Restylane treatments.
Restylane is a gel-based injection of hyaluronic acid, a compound that the body produces naturally. The gel reduces wrinkles and folds in the face, and can also add volume to the lips. Perlane and Perlane-L are also available as part of the Restylane product line. The injections create a more youthful-looking face, minimizing the appearance of a variety of wrinkles that occur around the nose and mouth area. People with severe allergies that have required hospitalization should not use Restylane products, nor should people with bleeding disorders. A doctor can help determine whether a person should or should not use Restylane treatments.
0 Comments
Dr. Coyle Connolly, founder of Connolly Dermatology specializing in general, surgical and cosmetic dermatology, has earned widespread media attention for his knowledge of skin cancer. Dr. Coyle Connolly draws on extensive experience with squamous cell carcinoma (SCC) diagnosis, prevention, and treatment.
A common cancer of the skin, SCC affects approximately 700,000 people in the United States alone. This marks a 200 percent increase in prevalence of the disease over the past 30 years. Prolonged exposure to the sun stands out as the disease's primary cause, though intense short-term exposure may increase a person's risk. Uncontrolled abnormal growth within the skin's squamous cells defines the condition. It presents as open sores or elevated growths on the skin, though many such growths may bleed or crust over as they grow. Potentially fatal if untreated, the condition led to the deaths of as many as 8,800 people nationwide in 2012. Survival rates increase dramatically with timely diagnosis and treatment, which may include surgery, topical medication, radiation, photodynamic therapy, or a combination of these measures. As president of Connolly Dermatology, a highly rated New Jersey medical practice, Dr. Coyle Connolly offers a variety of both cosmetic and clinical treatments. Dr. Coyle Connolly has performed numerous BOTOX Cosmetic procedures. His expertise and experience with Botox and other injectable anti aging products has made him a respected leader in the cosmetic field.
Designed to reduce moderate to deep frown lines and crow's feet, BOTOX Cosmetic is unique because it works within the facial muscles to limit movement of the skin. Under ordinary circumstances, facial wrinkles develop because the skin of the face folds and tucks when the individual squints or frowns. Over time, this repeated movement of the skin leads to lines that are visible even when the person's face is relaxed. Physicians inject BOTOX Cosmetic into the muscles that control these expressions. The cosmetic releases a chemical known as acetylcholine, which temporarily inhibits muscular activity in the area. This in turn protects the skin from folding and creasing and allows existing wrinkles to smooth. The effect typically lasts an average of three to four months, though some patients may see results up to six months after treatment. A board-certified dermatologist and clinical professor, Dr. Coyle Connolly is the president and founder of Connolly Dermatology, where he treats patients for both medical and cosmetic skin conditions. Coyle Connolly, D.O., and his team use state-of-the-art technology such as MelaFind, a noninvasive scanning device that detects atypical or abnormal moles and malignant melanoma.
Melanoma is the deadliest form of skin cancer, responsible for around three quarters of skin cancer fatalities; each hour, someone dies from melanoma in the United States. However, when detected early, the disease is nearly 100% curable. MelaFind is an FDA-approved optical imaging and data analysis device that helps a dermatologist gather information to determine whether to biopsy an irregular mole. Using light of 10 different wavelengths, the device takes noninvasive spectral imaging that offers 100% objective data. Then, sophisticated computer software analyzes the mole and informs the dermatologist of irregular growth patterns under the skin. This allows the dermatologist to more accurately identify melanoma in its early, most curable stages. |
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
May 2015
Categories
All
|